ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report
暂无分享,去创建一个
Michael D. Miller | S. Mathai | C. Spak | M. Askar | R. Gottlieb | K. Martits-Chalangari | A. Killian | T. Fisher | E. Atillasoy | W. Marshall | David McNeel | M. Miller | Michael D. Miller